Protagenic Therapeutics, Inc. (PTIX) Kompaniya qiymatining sof foydaga nisbati
Protagenic Therapeutics (PTIX) kompaniyasining P/E koeffitsiyenti tarixiga oid ushbu grafik hozirda -0.20 darajasini ko'rsatmoqda. Protagenic Therapeutics markaziy nerv tizimi (CNS) ma'lumotlar massivlarini qayta ishlash uchun dasturiy robotlarni joriy qilmoqda va avtomatlashtirilgan skrining stansiyalarini sinovdan o'tkazmoqda. Biznes xodimlarning rutiniy vazifalarini bartaraf etish uchun sintetik neuropeptidlar yaratuvchi bioinformatika IT platformalariga tayanadi. Xavotir va depressiyani davolash vositalarini ishlab chiqish yetakchi nerobiologik markazlar bilan hamkorlikda olib borilmoqda.
%20Narxning%20foydaga%20nisbati&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_PTIX_-_Protagenic-Therapeutics_-_Price-to-Earnings-Ratio "Protagenic Therapeutics (PTIX): Kapitalizatsiyaning foydaga nisbati 04.07.2022dan 10.01.2026gacha | 👁️GURU.Markets👁️")
Protagenic Therapeutics Inc. (PTIX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati Protagenic|PTIX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Protagenic Therapeutics, Inc.|PTIX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Protagenic Therapeutics|Oraliq qoplama koeffitsiyenti protagenic.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PTIX - Sof foyda|Kelajakdagi foyda Protagenic Therapeutics|PTIX - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Protagenic|PTIX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Protagenic Therapeutics, Inc.|PTIX - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Protagenic Therapeutics|PTIX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi protagenic.com|PTIX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Protagenic Therapeutics
Kompaniyaning jamlanma tahlili:PTIX (protagenic.com)
Protagenic Therapeutics (PTIX) depressiya va xavotir buzilishlarini davolash uchun neyroaktiv peptidlar ishlab chiqadi. P/E koeffitsiyenti aksiyaning joriy bozor qiymatini bir aksiya uchun sof foyda bilan bog'laydi. Protagenic Therapeutics (PTIX) kompaniyasining tarixiy P/E dinamikasini tahlil qilish orqali investor investitsiyaning qoplash muddatini aniqlaydi. Ushbu ko'rsatkich emitentning kelgusidagi pul oqimlari bo'yicha bozor kutganlarini o'lchaydi. Past qiymatlar aktivlarning qadrsizlanganini yoki fundamental biznes risklarini signalizatsiya qilishi mumkin.
Raqobatdosh kompaniyalar tahlili
biogen.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|RGC (Regencell Bioscience Ltd) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|XENE: Narx-foyda koeffitsiyenti|vikingtherapeutics.com - Bozor narxining sof foydaga nisbati|SUPN: P/E multiplikatori|Catalyst Pharma (CPRX) - P/E multiplikatori|DNLI (Denali Therapeutics Inc) - P/E multiplikatori|HRMY - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori BHVN|AMLX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|Anavex Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati CeriBell EEG CBLL|PRTA: P/E multiplikatori|Narx-foyda koeffitsiyenti Alector|Narx-foyda koeffitsiyenti ANNX|OMER: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti NGNE (Neurogene Corp)|Bozor narxining sof foydaga nisbati ACIU|P/E multiplikatori VYGR (Voyager Therapeutics)|Kompaniya qiymatining sof foydaga nisbati NMRA|Scilex - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Holdings Inc.|alphacognition.com (ACOG) - Narxning foydaga nisbati|Cognition Therapeutics Inc. - Kompaniya qiymatining sof foydaga nisbati|IKT (Inhibikase Therapeutics) - P/E multiplikatori|P/E multiplikatori cassavasciences.com|Narxning foydaga nisbati Assertio Holdings, Inc. (ASRT)|COYA: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS: Narx-foyda koeffitsiyenti|CRVO - P/E multiplikatori|ATHE (alteritytherapeutics.com) - Narx-foyda koeffitsiyenti|CLNN: Bozor narxining sof foydaga nisbati|PEPG (PepGen Inc) - P/E multiplikatori|Jupiter Neurosciences, Inc. (JUNS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori RLMD|Narx-foyda koeffitsiyenti annovisbio.com ANVS|Narxning foydaga nisbati Grace Therapeutics GRCE|Biznesning o‘zini qoplash muddati Firefly Neuroscience, Inc. (AIFF)|KLTO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati NRSN|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|MTVA: Bozor narxining sof foydaga nisbati|NRXS (NeurAxis) - P/E multiplikatori|Helius Medical Technologies Inc. (HSDT) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti PASG (Passage Bio, Inc.)|bionomics.com.au - Narx-foyda multiplikatori|Narxning foydaga nisbati Minerva Neurosciences NERV|ATHA: Narx-foyda multiplikatori|Addex Therapeutics Ltd - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alzamend Neuro, Inc.|CYCN (cyclerion.com) - Narx-foyda koeffitsiyenti|Pasithea Therapeutics Corp. (KTTA) - P/E multiplikatori|Narxning foydaga nisbati Cortigent Inc|ATXI: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|CARA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM (Eliem Therapeutics, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|ITCI - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati LBPH (longboardpharma.com)|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati NKGen Biotech Inc (NKGN)|Narx-foyda koeffitsiyenti NRBO|SAGE (Sage Therapeutics Inc) - Bozor narxining sof foydaga nisbati|P/E multiplikatori SNPX|P/E multiplikatori trevena.com (TRVN)|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti anewmeds.com|Cerevel - P/E multiplikatori
